Veeva Systems Inc (NYSE: VEEV) open the trading on Wednesday, with a bit cautious approach as it glided -4.21% to $218.86, before settling in for the price of $228.49 at the close. Taking a more long-term approach, VEEV posted a 52-week range of $201.54-$310.50.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 17.84%. Meanwhile, its Annual Earning per share during the time was 17.84%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 20.28%. This publicly-traded company’s shares outstanding now amounts to $164.34 million, simultaneously with a float of $149.94 million. The organization now has a market capitalization sitting at $35.98 billion.
Veeva Systems Inc (VEEV) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Health Information Services industry. Veeva Systems Inc’s current insider ownership accounts for 8.78%, in contrast to 87.82% institutional ownership. Preceding that transaction, on Oct 07 ’25, Company’s President & Chief of Staff sold 6,000 for 306.62, making the whole transaction’s value amount to 1,839,694. This particular insider is now the holder of 25,325 in total.
Veeva Systems Inc (VEEV) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.06 per share during the current fiscal year.
Veeva Systems Inc’s EPS increase for this current 12-month fiscal period is 20.28% and is forecasted to reach 8.58 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 14.05% through the next 5 years, which can be compared against the 17.84% growth it accomplished over the previous five years trading on the market.
Veeva Systems Inc (NYSE: VEEV) Trading Performance Indicators
Let’s observe the current performance indicators for Veeva Systems Inc (VEEV). It’s Quick Ratio in the last reported quarter now stands at 7.53. Alongside those numbers, its PE Ratio stands at $42.53, and its Beta score is 1.08. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 11.68. Similarly, its price to free cash flow for trailing twelve months is now 26.63.
In the same vein, VEEV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 5.15, a figure that is expected to reach 1.93 in the next quarter, and analysts are predicting that it will be 8.58 at the market close of one year from today.
